Parenteral ketorolac: The risk for acute renal failure

Annals of Internal Medicine

Volumn 126, Issue 3, 1997, Pages 193-199

  Feldman, Harold I ^a   Kinman, Judith L ^a   Berlin, Jesse A ^a   Hennessy, Sean ^a   Kimmel, Stephen E ^a   Farrar, John ^a   Carson, Jeffrey L ^b   Strom, Brian L ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; KETOROLAC;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CREATININE BLOOD LEVEL; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0031053255     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-126-3-199702010-00003     Document Type: Article

References (31)

1. Buckley MM, Brogden RN. Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs. 1990;39: 86-109.
2. Clive DM, Stoff JS. Renal, syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med. 1984;310:563-72.
3. Kleinknecht D, Landais P, Goldfarb B. Analgesic and non-steroidal antiinflammatory drug-associated acute renal failure: a prospective collaborative study. Clin Nephrol. 1986;25:275-81.
4. McCarthy JT, Schwartz GL, Blair TJ, Pierides AM. Van den Berg CJ. Reversible nonoliguric acute renal failure associated with zomepirac therapy. Mayo Clin Proc. 1982;57:351-4.
5. McCarthy JT, Torres VE, Romero JC, Wochos DN, Velosa JA. Acute intrinsic renal failure induced by indomethacin: role of prostaglandin synthetase inhibition. Mayo Clin Proc. 1982;57:289-96.
6. Fong HJ, Cohen AH. Ibuprofen-induced acute renal failure with acute tubular necrosis. Am J Nephrol. 1982;2:28-31.
7. Henann NE, Morales JR. Suprofen-induced acute renal failure. Drug Intell Clin Pharm. 1986;20:860-2.
8. Whelton A, Stout RL, Spilman PS, Klassen DK. Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure. A prospective, randomized, crossover comparison. Ann Intern Med. 1990;112:568-76.
9. Gurwitz JH, Avorn J, Ross-Degnan D, Lipsitz LA. Nonsteroidal antiinflammatory drug-associated azotemia in the very old. JAMA. 1990;264: 471-5.
10. Fong HJ, Cohen AH. Ibuprofen-induced acute renal failure with acute tubular necrosis. Am J Nephrol. 1982;2:28-31.
11. Kimberly RP, Sherman RL, Mouradian J, Lockshin MD. Apparent acute renal failure associated with therapeutic aspirin and ibuprofen administration. Arthritis Rheum. 1979;22:281-5.
12. Rotenberg FA, Giannini VS. Hyperkalemia associated with ketorolac. Ann Pharmacother. 1992;26:778-9.
13. Whelton A. Renal effects of over-the-counter analgesics. J Clin Pharmacol. 1995;35:454-63.
14. Schlondorff D. Renal complications of nonsteroidal anti-inflammatory drugs. Kidney Int. 1993;44:643-53.
15. Favre L, Glasson P, Vallotton MB. Reversible acute renal failure from combined triamterene and indomethacin: a study in healthy subjects. Ann Intern Med. 1982;96:317-20,
16. Marasco WA, Gikas PW, Azziz-Baumgartner R, Hyzy R, Eldredge CJ, Stross J. Ibuprofen-associated renal dysfunction. Pathophysiologic mechanisms of acute renal failure hyperkalemia, tubular necrosis, and proteinuria. Arch Intern Med. 1997;147:2107-16.
17. Galler M, Folkert VW, Schlondorff D. Reversible acute renal insufficiency and hyperkalemia following indomethacn therapy, JAMA. 1981;246:154-5.
18. Quintero E, Gines P, Arroyo V, Rimola A, Camps J, Gaya J, et al. Sulindac reduces the urinary excretion of prostaglandins and impairs renal function in cirrhosis with ascites, Nephron. 1986;42:298-303.
19. Smith K, Halliweil RM, Lawrence S, Klineberg PL, O'Connell P. Acute renal failure associated with intramuscular ketorolac. Anaesth Intensive Care. 1993;21:700-2.
20. Schoch PH, Ranno A, North DS. Acute renal failure in an elderly woman following intramuscular ketorolac administration. Ann Pharmacother. 1992; 26:1233-6.
21. Corelli RL Gericke KR. Renal insufficiency associated with intramuscular administration of ketorolac tromethamine. Ann Pharmacother. 1993;27:1055-7.
22. Perazelia MA, Buller GK. NSAID nephrotoxicity revisited: acute renal failure due to parenteral ketorolac. South Med J. 1993;86:1421-4.
23. Boras-Uber LA, Brackett NC Jr. Ketorolac-induced acute renal failure [Letter]. Am J Med. 1992;92:450-2.
24. Haragsim L, Dalal R, Bagga H, Bastani B. Ketorolac-induced acute renal failure and hyperkalemia: report of three cases. Am J Kidney Dis. 1994;24: 578-80.
25. Quan DJ, Kayser SR. Ketorolac induced acute renal failure following a single dose. J Toxicol Clin Toxicol. 1994;32:305-9.
26. Fong J, Gora ML. Reversible renal insufficiency following ketorolac therapy [Letter]. Ann Pharmacother. 1993;27:510-2.
27. Epelde Gonzalo FD, Llibre Bombardo J, Tomas Vecina S. [Ketorolacinduced acute kidney failure (Letter)]. Rev Clin Esp. 1994;194:515.
28. Strom BL, Barlin JA, Kinman JL, Spitz PW, Hennessy S, Feidman H, et al. Parenteral ketorolac and risk of gastrointestinal and operative site bleeding. A postmarketing surveillance study. JAMA. 1995;275:376-82.
29. Remington RD, Schork MA. Statistics with Applications to the Biological and Health Sciences, 2d ed, Englewood Cliffs, NJ: Prentice-Hall; 1985:187-9, 210-8.
30. Lee ET. Statistical Methods for Survival Data Analysis. Belmont, CA: Lifetime Learning; 1980.
31. Cox DR. Regression models and life tables. Journal of the Royal Statistical Society. 1972;34:187.